COVID-19 is not getting worse in the way it was during the early pandemic years. Hospitalizations and deaths have dropped dramatically from their peaks, and the virus now accounts for roughly 0.3% of all deaths in the United States. But “getting better” comes with caveats: the virus continues to evolve in ways that help it dodge your immune system, it still surges twice a year, and it remains capable of causing serious illness in vulnerable groups. The honest answer is that COVID has settled into a pattern that’s less deadly overall but far from finished.
What the Virus Is Doing Now
SARS-CoV-2 hasn’t stopped mutating. As of mid-2025, the dominant lineages globally include XFG (most common in North America and Europe and expanding fast) and NB.1.8.1 (prevalent in Asia and Oceania). These replaced the LP.8.1 family that circulated through the spring. The key difference between the older and newer variants isn’t raw infectiousness. LP.8.1 appeared to bind more tightly to human cells, making it more infectious. The newer XFG and NB.1.8.1 lineages instead carry mutations that are better at evading antibodies, including those generated by vaccines and prior infections.
One mutation worth noting, T22N, adds a sugar molecule to the spike protein’s surface. This sugar, along with other substitutions, essentially disguises the parts of the virus that your immune system has learned to recognize. The result: even if you’ve been vaccinated and previously infected, these variants have an easier time slipping past your defenses. That doesn’t mean your immunity is useless. It means infections are more likely to happen, though your body still mounts a faster response than it would with no prior exposure at all.
Severity Has Dropped, but Surges Still Happen
The numbers paint a clear picture of declining severity at the population level. In mid-April 2026, the COVID-19 hospitalization rate was 0.4 per 100,000 people, and wastewater viral activity was classified as “very low” nationally. Compare that to the winter peaks of earlier years, when hospitals were overwhelmed and death tolls dominated headlines.
That said, COVID hasn’t become a one-season illness. Over the past three years, the U.S. has experienced two waves annually: one in summer and one in winter. CDC scenario modeling projects a peak in late August 2025 and another in January 2026, consistent with this pattern. The winter peak typically hits hardest in late December or early January. These surges aren’t as catastrophic as they once were, but they’re predictable enough that high-risk individuals should plan around them.
How Symptoms Have Changed
If you’ve caught COVID recently and it felt more like a bad cold than the flu, that’s the general trend. Since Omicron became dominant, COVID infections have shifted heavily toward upper respiratory symptoms: cough (about 63% of cases), sore throat (61%), runny nose (44%), and fever (39%). The earlier Wuhan-era pattern of high fever, shortness of breath, crushing fatigue, and loss of taste or smell has become much less common, particularly in vaccinated people.
Vaccination plays a direct role in this shift. People with three or more vaccine doses are roughly half as likely to develop fever and significantly less likely to experience severe fatigue, joint pain, diarrhea, or breathing difficulty compared to those with fewer doses. The tradeoff is that vaccinated people are actually more likely to report runny nose, cough, and sore throat. This isn’t a downside. It reflects the infection staying in the upper airways rather than moving deeper into the lungs, which is exactly what you want.
For older adults, the type of symptoms still matters as a warning sign. Shortness of breath, fever, loss of appetite, and severe fatigue in elderly patients are each associated with a two- to threefold increase in the risk of severe disease. Conversely, when older adults present mainly with a sore throat and runny nose, their risk of a bad outcome drops significantly. These patterns can help families gauge when a COVID infection in an elderly relative warrants closer attention.
How Well Vaccines and Treatments Work
The updated 2024-2025 COVID vaccine offers moderate protection. For adults 18 and older, it reduces the risk of an emergency department or urgent care visit by 33% within the first four months after vaccination. For immunocompetent adults 65 and older, effectiveness against hospitalization is higher: 45% to 46%. For older adults with weakened immune systems, it’s about 40%.
These numbers are lower than what many people expect from a vaccine, but they’re consistent with how flu vaccines perform in a typical year. The protection is most meaningful for people at highest risk of hospitalization, where cutting the odds nearly in half can be the difference between recovering at home and a week in the hospital.
On the treatment side, the antiviral Paxlovid continues to work against Omicron-era variants. A large study of over 700,000 patients found it reduced the risk of hospitalization by 39%. The absolute risk reduction was about 1 percentage point, which sounds small but is clinically significant for high-risk patients. Paxlovid needs to be started within the first five days of symptoms to be effective, so getting tested early matters if you’re in a vulnerable group.
Long COVID Risk Is Lower but Not Gone
One of the most important questions about whether COVID is “getting worse” involves long COVID, the constellation of symptoms that can persist for months after infection. Data from the RECOVER Initiative, which tracked patients from 2020 through 2024 using electronic health records, found that roughly 10% to 26% of adults developed long COVID after infection, depending on how it was measured. Among children, the rate was about 4%.
When researchers compared infected patients to uninfected control groups, the excess incidence (the portion attributable specifically to COVID rather than background illness) was about 5% to 6% in adults and 1.5% in children. These are lower-bound estimates, but they suggest that for every 100 adults infected, somewhere between 5 and 6 will develop persistent symptoms they wouldn’t have experienced otherwise.
Incidence peaked with the introduction of new variants, suggesting that immune evasion plays a role. Each time a variant circulates that your antibodies don’t recognize as well, the infection may gain a stronger foothold, and the chance of lingering effects ticks upward. Vaccination and prior infection don’t eliminate long COVID risk, but the overall trend has been toward lower rates of severe, prolonged illness compared to the early pandemic years.
The Bottom Line on Where COVID Stands
COVID is less deadly than it was in 2020 or 2021 by a wide margin. Population-level immunity from billions of infections and vaccinations worldwide has transformed it from a mass-casualty emergency into a recurring respiratory illness with a predictable seasonal rhythm. But the virus keeps evolving to sidestep that immunity, and it still hospitalizes and kills people, disproportionately the elderly and immunocompromised. It’s not getting worse in severity. It is getting better at finding people whose protection has gaps.